Schedule a Meeting

    Our Team at CPHI Milan 2026

    Dr. Abhinav Gorukanti
    Dr. Abhinav Gorukanti

    Chief Executive Officer

    Bhaskar Viswanathan
    Mr. Satnam Singh

    Chief Operating Officer

    Bhaskar Viswanathan
    Mr. Bhaskar Viswanathan

    VP, Business Development

    Rahul TS
    Mr. Nimesh Kumar Suthar

    Senior VP – Business Development

    Charan Kalakuntla
    Charan Kalakuntla

    Chief of Staff

    Akarshan Gupta
    Mr. Akarshan Gupta

    GM – Business Development

    Rahul TS
    Rahul TS

    DGM – Business Development

    Dr. Abhinav Gorukanti
    Mr. Shanmukh Rao Kota

    DGM – Business Development

    Dr. Abhinav Gorukanti
    Mr. Nikhil N Bhandari

    DGM – Business Development,
    (MENA & Emerging Markets)

    Bhaskar Viswanathan
    Mr. Faizan Qureshi

    Senior Executive –
    Business Development

    Charan Kalakuntla
    Mr. Akash Suresh Bharti

    Executive – Business Development

    About Anthea Pharma

    Anthea Pharma, established in 2019 is a young, R&D focused Injectables firm, backed by the prestigious Yashoda Group. Based out of Hyderabad, India, Anthea Pharma has a world class R&D facility, and an injectable manufacturing facility, currently capable of manufacturing liquid Vials, Emulsions, PFS, Lyophilized Vials and Ampoules. Anthea Pharma envisions to manufacture for the world and be a global firm focused on injectables needs with consistent supply of highest-quality products across therapeutic segments. Our deep relationships in the healthcare and life science segment has enabled us to secure the backing of Yashoda Group, weaving a compelling blend of Hospitals, Pharmaceuticals, and Real Estate.

    About CPHI Milan 2026

    With a focus on fostering innovation and collaboration, CPHI Milan brings together key players across the pharmaceutical and biotech industries & offers attendees a unique opportunity to explore cutting-edge technologies, products, and services that are shaping the future of pharmaceuticals.

    Key Highlights of CPHI Milan 2026:

    Global Participation: The event expects to welcome 60,000+ attendees and 2,400+ exhibitors from 168+ countries, demonstrating its significant international reach.

    Diverse Exhibition: Attendees can explore a wide range of products and services across various pharmaceutical sectors.

    Networking Opportunities: CPHI Milan offers numerous opportunities for attendees to connect, build relationships, and forge partnerships.

    Celebration of over 35 Years: CPHI Milan 2026 marks a special milestone, celebrating over 35 years of uniting the pharma community.